Han H - Search Results

1

Deprogramming metabolism in pancreatic cancer with a bi-functional GPR55 inhibitor and biased β₂ adrenergic agonist.

Wnorowski A, Dudzik D, Bernier M, Wójcik J, Keijzers G, Diaz-Ruiz A, Mazur K, Zhang Y, Han H, Scheibye-Knudsen M, Jozwiak K, Barbas C, Wainer IW. Wnorowski A, et al. Among authors: han h. Sci Rep. 2022 Mar 7;12(1):3618. doi: 10.1038/s41598-022-07600-x. Sci Rep. 2022. PMID: 35256673 Free PMC article.

2

Gene expression profiling-based identification of cell-surface targets for developing multimeric ligands in pancreatic cancer.

Balagurunathan Y, Morse DL, Hostetter G, Shanmugam V, Stafford P, Shack S, Pearson J, Trissal M, Demeure MJ, Von Hoff DD, Hruby VJ, Gillies RJ, Han H. Balagurunathan Y, et al. Among authors: han h. Mol Cancer Ther. 2008 Sep;7(9):3071-80. doi: 10.1158/1535-7163.MCT-08-0402. Epub 2008 Sep 2. Mol Cancer Ther. 2008. PMID: 18765825 Free PMC article.

3

Validation of TPX2 as a potential therapeutic target in pancreatic cancer cells.

Warner SL, Stephens BJ, Nwokenkwo S, Hostetter G, Sugeng A, Hidalgo M, Trent JM, Han H, Von Hoff DD. Warner SL, et al. Among authors: han h. Clin Cancer Res. 2009 Nov 1;15(21):6519-28. doi: 10.1158/1078-0432.CCR-09-0077. Epub 2009 Oct 27. Clin Cancer Res. 2009. PMID: 19861455 Free PMC article.

4

Synergistic effect between erlotinib and MEK inhibitors in KRAS wild-type human pancreatic cancer cells.

Diep CH, Munoz RM, Choudhary A, Von Hoff DD, Han H. Diep CH, et al. Among authors: han h. Clin Cancer Res. 2011 May 1;17(9):2744-56. doi: 10.1158/1078-0432.CCR-10-2214. Epub 2011 Mar 8. Clin Cancer Res. 2011. PMID: 21385921 Free PMC article.

5

Tumor-stromal interactions in pancreatic cancer.

Whatcott C, Han H, Posner RG, Von Hoff DD. Whatcott C, et al. Among authors: han h. Crit Rev Oncog. 2013;18(1-2):135-51. doi: 10.1615/critrevoncog.v18.i1-2.80. Crit Rev Oncog. 2013. PMID: 23237556 Free PMC article. Review.

6

SnapShot: pancreatic cancer.

Han H, Von Hoff DD. Han H, et al. Cancer Cell. 2013 Mar 18;23(3):424-424.e1. doi: 10.1016/j.ccr.2013.03.008. Cancer Cell. 2013. PMID: 23518352 Free PMC article. No abstract available.

7

Blocking Nerve Growth Factor Signaling Reduces the Neural Invasion Potential of Pancreatic Cancer Cells.

Bapat AA, Munoz RM, Von Hoff DD, Han H. Bapat AA, et al. Among authors: han h. PLoS One. 2016 Oct 28;11(10):e0165586. doi: 10.1371/journal.pone.0165586. eCollection 2016. PLoS One. 2016. PMID: 27792755 Free PMC article.

8

Identification and characterization of a novel anticancer agent with selectivity against deleted in pancreatic cancer locus 4 (DPC4)-deficient pancreatic and colon cancer cells.

Wang H, Stephens B, Von Hoff DD, Han H. Wang H, et al. Among authors: han h. Pancreas. 2009 Jul;38(5):551-7. doi: 10.1097/MPA.0b013e31819d7415. Pancreas. 2009. PMID: 19276868

9

Curcumin sensitizes pancreatic cancer cells to gemcitabine by attenuating PRC2 subunit EZH2, and the lncRNA PVT1 expression.

Yoshida K, Toden S, Ravindranathan P, Han H, Goel A. Yoshida K, et al. Among authors: han h. Carcinogenesis. 2017 Oct 1;38(10):1036-1046. doi: 10.1093/carcin/bgx065. Carcinogenesis. 2017. PMID: 29048549 Free PMC article.

10

KRAS Suppression-Induced Degradation of MYC Is Antagonized by a MEK5-ERK5 Compensatory Mechanism.

Vaseva AV, Blake DR, Gilbert TSK, Ng S, Hostetter G, Azam SH, Ozkan-Dagliyan I, Gautam P, Bryant KL, Pearce KH, Herring LE, Han H, Graves LM, Witkiewicz AK, Knudsen ES, Pecot CV, Rashid N, Houghton PJ, Wennerberg K, Cox AD, Der CJ. Vaseva AV, et al. Among authors: han h. Cancer Cell. 2018 Nov 12;34(5):807-822.e7. doi: 10.1016/j.ccell.2018.10.001. Cancer Cell. 2018. PMID: 30423298 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,025 results

Search Page

Filters